• Advising various companies on Commonwealth and State/Territory regulatory regimes for medicinal cannabis cultivation, production, manufacture and supply
• Advice on the Federal and State regulatory regimes for patient access to medicinal cannabis products
• Ongoing advice about the regulation of therapeutic goods, particularly the merits of decisions by the TGA; section 60 and AT appeals; ongoing advice about application of the legislation and guidelines; and proper administrative process
• Advice to an originator company regarding price implications arising from the listing of a generic competitor, including advice on applicable statutory provisions and negotiations with the Department of Health to achieve a commercially acceptable
• Advice to various originator companies in relation to alleged disclosures by the Department of Health of confidential information in risk-share deeds
• Acting for an originator against a generic company alleging misleading and deceptive conduct in relation to various claims made in promotional material
• Ongoing negotiation and drafting of commercial agreements for the supply and distribution of pharmaceutical products (3PL and 4PL).

Webinars

• Advertising Therapeutic Goods Legal Issues: War Stories from the Courts
• Therapeutic Goods Act Boundary Issues
• State and Territory Laws Regulating the Possession and Supply of Medicines